Compass Therapeutics, Inc.

Report date
9/30/2025
Quarter
2025 Q3
Filed
2/17/2026
Shares
80,000
Value ($000)
280
Weight
0.0%
2024 Q3 - 2025 Q3 (5 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).